Search Page

1

Cite

Share

Structure Modeling of the Norepinephrine Transporter.

Góral I, Łątka K, Bajda M. Góral I, et al. Among authors: bajda m. Biomolecules. 2020 Jan 7;10(1):102. doi: 10.3390/biom10010102. Biomolecules. 2020. PMID: 31936154 Free PMC article.

Cite

Share

2

Cite

Share

Structure modeling of γ-aminobutyric acid transporters - Molecular basics of ligand selectivity.

Łątka K, Jończyk J, Bajda M. Łątka K, et al. Among authors: bajda m. Int J Biol Macromol. 2020 May 3:S0141-8130(20)33135-4. doi: 10.1016/j.ijbiomac.2020.04.263. Online ahead of print. Int J Biol Macromol. 2020. PMID: 32376252 Free article.

Cite

Share

3

Cite

Share

Search for new multi-target compounds against Alzheimer's disease among histamine H₃ receptor ligands.

Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B. Bajda M, et al. Eur J Med Chem. 2020 Jan 1;185:111785. doi: 10.1016/j.ejmech.2019.111785. Epub 2019 Oct 17. Eur J Med Chem. 2020. PMID: 31669851

Cite

Share

4

Cite

Share

Novel application of capillary electrophoresis with a liposome coated capillary for prediction of blood-brain barrier permeability.

Godyń J, Gucwa D, Kobrlova T, Novak M, Soukup O, Malawska B, Bajda M. Godyń J, et al. Among authors: bajda m. Talanta. 2020 Sep 1;217:121023. doi: 10.1016/j.talanta.2020.121023. Epub 2020 Apr 11. Talanta. 2020. PMID: 32498842 Free article.

Cite

Share

5

Cite

Share

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.

Czarnecka K, Girek M, Wójtowicz P, Kręcisz P, Skibiński R, Jończyk J, Łątka K, Bajda M, Walczak A, Galita G, Kabziński J, Majsterek I, Szymczyk P, Szymański P. Czarnecka K, et al. Among authors: bajda m. Int J Mol Sci. 2020 May 26;21(11):3765. doi: 10.3390/ijms21113765. Int J Mol Sci. 2020. PMID: 32466601 Free PMC article.

Cite

Share

6

Cite

Share

Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease.

Szałaj N, Godyń J, Jończyk J, Pasieka A, Panek D, Wichur T, Więckowski K, Zaręba P, Bajda M, Pislar A, Malawska B, Sabate R, Więckowska A. Szałaj N, et al. Among authors: bajda m. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1944-1952. doi: 10.1080/14756366.2020.1835882. J Enzyme Inhib Med Chem. 2020. PMID: 33092411 Free PMC article.

Cite

Share

7

Cite

Share

Rational design of new multitarget histamine H₃ receptor ligands as potential candidates for treatment of Alzheimer's disease.

Łażewska D, Bajda M, Kaleta M, Zaręba P, Doroz-Płonka A, Siwek A, Alachkar A, Mogilski S, Saad A, Kuder K, Olejarz-Maciej A, Godyń J, Stary D, Sudoł S, Więcek M, Latacz G, Walczak M, Handzlik J, Sadek B, Malawska B, Kieć-Kononowicz K. Łażewska D, et al. Among authors: bajda m. Eur J Med Chem. 2020 Dec 1;207:112743. doi: 10.1016/j.ejmech.2020.112743. Epub 2020 Aug 21. Eur J Med Chem. 2020. PMID: 32882609

Cite

Share

8

Cite

Share

Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.

Bajda M, Łątka K, Hebda M, Jończyk J, Malawska B. Bajda M, et al. Bioorg Chem. 2018 Aug;78:29-38. doi: 10.1016/j.bioorg.2018.03.003. Epub 2018 Mar 3. Bioorg Chem. 2018. PMID: 29529519

Cite

Share

9

Cite

Share

γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases.

Łątka K, Jończyk J, Bajda M. Łątka K, et al. Among authors: bajda m. Int J Biol Macromol. 2020 Apr 30:S0141-8130(20)32987-1. doi: 10.1016/j.ijbiomac.2020.04.126. Online ahead of print. Int J Biol Macromol. 2020. PMID: 32360967 Free article.

Cite

Share

10

Cite

Share

Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

Musiał A, Bajda M, Malawska B. Musiał A, et al. Among authors: bajda m. Curr Med Chem. 2007;14(25):2654-79. doi: 10.2174/092986707782023217. Curr Med Chem. 2007. PMID: 17979717 Review.

Cite

Share